Thomas L. Poulos

High-resolution crystal structure of cytochrome P450cam.

The crystal structure of Pseudomonas putida cytochrome P450cam with its substrate, camphor, bound has been refined to R = 0.19 at a normal resolution of 1.63 A. While the 1.63 A model confirms our initial analysis based on the 2.6 A model, the higher resolution structure has revealed important new details. These include a more precise assignment of sequence to secondary structure, the identification of three cis-proline residues, and a more detailed picture of substrate-protein interactions. In addition, 204 ordered solvent molecules have been found, one of which appears to be a cation. The cation stabilizes an unfavorable polypeptide conformation involved in forming part of the active site pocket, suggesting that the cation may be the metal ion binding site associated with the well-known ability of metal ions to enhance formation of the enzyme-substrate complex. Another unusual polypeptide conformation forms the proposed oxygen-binding pocket. A localized distortion and widening of the distal helix provides a pocket for molecular oxygen. An intricate system of side-chain to backbone hydrogen bonds aids in stabilizing the required local disruption in helical geometry. Sequence homologies strongly suggest a common oxygen-binding pocket in all P450 species. Further sequence comparisons between P450 species indicate common three-dimensional structures with changes focused in a region of the molecule postulated to be associated with the control of substrate specificity.

Crystal Structure of Constitutive Endothelial Nitric Oxide Synthase: A Paradigm for Pterin Function Involving a Novel Metal Center

Nitric oxide, a key signaling molecule, is produced by a family of enzymes collectively called nitric oxide synthases (NOS). Here, we report the crystal structure of the heme domain of endothelial NOS in tetrahydrobiopterin (H4B)-free and -bound forms at 1.95 A and 1.9 A resolution, respectively. In both structures a zinc ion is tetrahedrally coordinated to pairs of symmetry-related cysteine residues at the dimer interface. The phylogenetically conserved Cys-(X)4-Cys motif and its strategic location establish a structural role for the metal center in maintaining the integrity of the H4B-binding site. The unexpected recognition of the substrate, L-arginine, at the H4B site indicates that this site is poised to stabilize a positively charged pterin ring and suggests a model involving a cationic pterin radical in the catalytic cycle.

Crystal Structure of Cytochrome P450 14Alpha -Sterol Demethylase (Cyp51) from Mycobacterium Tuberculosis in Complex with Azole Inhibitors

Cytochrome P450 14α-sterol demethylases (CYP51) are essential enzymes in sterol biosynthesis in eukaryotes. CYP51 removes the 14α-methyl group from sterol precursors such as lanosterol, obtusifoliol, dihydrolanosterol, and 24(28)-methylene-24,25-dihydrolanosterol. Inhibitors of CYP51 include triazole antifungal agents fluconazole and itraconazole, drugs used in treatment of topical and systemic mycoses. The 2.1- and 2.2-Å crystal structures reported here for 4-phenylimidazole- and fluconazole-bound CYP51 from Mycobacterium tuberculosis (MTCYP51) are the first structures of an authentic P450 drug target. MTCYP51 exhibits the P450 fold with the exception of two striking differences—a bent I helix and an open conformation of BC loop—that define an active site-access channel running along the heme plane perpendicular to the direction observed for the substrate entry in P450BM3. Although a channel analogous to that in P450BM3 is evident also in MTCYP51, it is not open at the surface. The presence of two different channels, with one being open to the surface, suggests the possibility of conformationally regulated substrate-in/product-out openings in CYP51. Mapping mutations identified in Candida albicans azole-resistant isolates indicates that azole resistance in fungi develops in protein regions involved in orchestrating passage of CYP51 through different conformational stages along the catalytic cycle rather than in residues directly contacting fluconazole. These new structures provide a basis for rational design of new, more efficacious antifungal agents as well as insight into the molecular mechanism of P450 catalysis.

Heme Enzyme Structure and Function

Metalloporphyrins are widely used throughout the biosphere and of these heme (iron protoporphyrin IX, Fig. 1) is one of the most abundant and widely used. Heme shuttles electrons between proteins as in mitochondrial respiration or transports and stores O2 as with the globins. The role of heme in more active enzymatic chemical transformation began to be appreciated just after the discovery by Mason1 and Hayaishi2 that O2 O atoms can be enzymatically incorporated into organic substrates which represented the seminal discovery of oxygenases. While the enzymes used in these studies did not contain heme, it was not too long before heme-containing oxygenases also were discovered. In 1958 Klingenberg3 and Garfinkel4 found an unusual pigment in microsomes that when reduced in the presence of CO generated a spectrum with a peak at 450 nm instead of the expected 420 nm peak. Hence the name P450 was born. In 1964 Omura and Sato5,6 showed that this “pigment” is actually a protein and the function of this strange heme protein became clear in a seminal study by Estabrook et al.7 that demonstrated the involvement of the 450 nm pigment in steroid hydroxylation. Thus by the mid-1960s it was established that heme plays an active role in biology by somehow catalyzing the hydroxylation of organic substrates. While these discoveries certainly mark the beginning of modern approaches to studying heme enzyme oxygenases, the enzymatic role of heme dates much earlier to 1903 when horseradish peroxidase (HRP) was described.8 Indeed, owing to the ease of purification and stability of the various intermediates, HRP dominated heme enzyme studies until P450 was discovered. Figure 1 Structure of iron protoporphyrin IX. Heme enzymes can catalyze both reductive and oxidative chemistry but here we focus on those that catalyze oxidation reactions, and especially those for which crystal structures are available. There are two broad classes of heme enzyme oxidants: oxygenases that use O2 to oxidize, usually oxygenate, substrates and peroxidases that use H2O2 to oxidize, but not normally oxygenate, substrates. Of the two oxidants molecular oxygen is the most unusual because even though the oxidation of nearly all biological molecules by O2 is a thermodynamically favorable process, O2 is not a reactive molecule. The reason, of course, is that there is a large kinetic barrier to these reactions owing to O2 being a paramagnetic molecule so the reaction between a majority of biological molecules that have paired spins is a spin forbidden process. Overcoming this barrier is why Nature recruited transition metals and heme into enzyme active sites. As shown in Fig. 2, heme oxygenases bind O2 and store the O2 oxidizing equivalents in the iron, porphyrin, and/or amino acid side chains for further selective oxidation of substrates. Peroxidases use H2O2 as the oxidant and while not having the O2 spin barrier, H2O2 presents its own problems. The reaction between H2O2 and transition metals generates toxic hydroxyl radicals in the well known Fenton chemistry9 which would be highly destructive to enzyme active sites. As illustrated in Fig. 2, all heme oxidases are at some point in the catalytic cycle peroxidases. Molecular oxygen must first be reduced by two electrons to the peroxide level before the interesting chemistry starts: cleavage of the O-O bond. This bond can cleave either homolytically, which gives two hydroxyl radicals, or heterolytically to effectively give H2O and a naked O atom with only 6 valence electrons. Since the release of hydroxyl radicals in the active site must, in most cases, be avoided Nature has engineered heme enzyme active sites to ensure that the heterolytic pathway dominates. Figure 2 Oxygen and peroxide activation by heme enzymes. Oxygenases like P450 must have the iron reduced to ferrous (Fe(II) or Fe2+) before O2 can bind. The oxy complex is best described as ferric-superoxide, Fe(III)-OO−. A second electron transfer results ... The list of heme enzymes is substantial and thus it is necessary to be selective on which to discuss in detail. It may appear that a disproportionate amount of space is devoted to peroxidases and P450s. This is true and admittedly reflects the author’s own interests and area of expertise. Additionally, however, peroxidases are the most extensively studied heme enzymes and have provided fundamental insights into the chemistry and structure shared by many other enzymes. The other enzymes to be discussed were selected owing to both subtle variations on common themes and novel features that Nature selected for specific biological function.

Crystal structure of human heme oxygenase-1

Heme oxygenase catalyzes the first step in the oxidative degradation of heme. The crystal structure of heme oxygenase-1 (HO-1) reported here reveals a novel helical fold with the heme sandwiched between two helices. The proximal helix provides a heme iron ligand, His 25. Conserved glycines in the distal helix near the oxygen binding site allow close contact between the helix backbone and heme in addition to providing flexibility for substrate binding and product release. Regioselective oxygenation of the α-meso heme carbon is due primarily to steric influence of the distal helix.

The crystal structure of peanut peroxidase.

BACKGROUND Peroxidases catalyze a wide variety of peroxide-dependent oxidations. Based on sequence alignments, heme peroxidases have been divided into three classes. Crystal structures are available for peroxidases of classes I and II, but until now no structure has been determined for class III, the classical extracellular plant peroxidases. RESULTS The crystal structure of peanut peroxidase has been solved to 2.7 A resolution. The helical fold is similar to that of known peroxidase structures. The 294-residue polypeptide chain is accompanied by a heme and two calcium ions, and there is some evidence of glycosylation. CONCLUSIONS This is the first complete structure of a class III peroxidase and as such should serve as a model for other class III enzymes including the much-studied horseradish peroxidase. It may also aid in the interpretation of functional differences between the peroxidase classes. Ten helices conserved in class I and II peroxidases are also found in peanut peroxidase. Key residues of the heme environment and the location of two calcium ions are shared with class II peroxidases. Peanut peroxidase contains three unique helices, two of which contribute to the substrate access channel leading to the heme edge.

Structure of the CO sensing transcription activator CooA

CooA is a homodimeric transcription factor that belongs to the catabolite activator protein (CAP) family. Binding of CO to the heme groups of CooA leads to the transcription of genes involved in CO oxidation in Rhodospirillum rubrum. The 2.6 Å structure of reduced (Fe2+) CooA reveals that His 77 in both subunits provides one heme ligand while the N-terminal nitrogen of Pro 2 from the opposite subunit provides the other ligand. A structural comparison of CooA in the absence of effector and DNA (off state) with that of CAP in the effector and DNA bound state (on state) leads to a plausible model for the mechanism of allosteric control in this class of proteins as well as the CO dependent activation of CooA.

Crystal structure of a thermophilic cytochrome P450 from the archaeon Sulfolobus solfataricus.

The structure of the first P450 identified in Archaea, CYP119 from Sulfolobus solfataricus, has been solved in two different crystal forms that differ by the ligand (imidazole or 4-phenylimidazole) coordinated to the heme iron. A comparison of the two structures reveals an unprecedented rearrangement of the active site to adapt to the different size and shape of ligands bound to the heme iron. These changes involve unraveling of the F helix C-terminal segment to extend a loop structure connecting the F and G helices, allowing the longer loop to dip down into the active site and interact with the smaller imidazole ligand. A comparison of CYP119 with P450cam and P450eryF indicates an extensive clustering of aromatic residues may provide the structural basis for the enhanced thermal stability of CYP119. An additional feature of the 4-phenylimidazole-bound structure is a zinc ion tetrahedrally bound by symmetry-related His and Glu residues.

Crystal structures of zinc-free and -bound heme domain of human inducible nitric-oxide synthase. Implications for dimer stability and comparison with endothelial nitric-oxide synthase.

The crystal structures of the heme domain of human inducible nitric-oxide synthase (NOS-2) in zinc-free and -bound states have been solved. In the zinc-free structure, two symmetry-related cysteine residues form a disulfide bond. In the zinc-bound state, these same two cysteine residues form part of a zinc-tetrathiolate (ZnS4) center indistinguishable from that observed in the endothelial isoform (NOS-3). As in NOS-3, ZnS4 plays a key role in stabilizing intersubunit contacts and in maintaining the integrity of the cofactor (tetrahydrobiopterin) binding site of NOS-2. A comparison of NOS-2 and NOS-3 structures illustrates the conservation of quaternary structure, tertiary topology, and substrate and cofactor binding sites, in addition to providing insights on isoform-specific inhibitor design. The structural comparison also reveals that pterin binding does not preferentially stabilize the dimer interface of NOS-2 over NOS-3.

The role of the proximal ligand in heme enzymes

Abstract Several new heme enzyme crystal structures have revealed similarities and differences in the local environment of the proximal heme ligand. This information, together with protein engineering studies, has provided important advances in understanding the role of the proximal ligand in heme enzyme catalysis. These advances include the ligands role in the O–O bond cleavage reaction, stabilization of the Fe(IV)=O intermediate and control of the heme iron redox potential.